{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:23:28Z","timestamp":1794489808619,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015027","name":"Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["140008186855"],"award-info":[{"award-number":["140008186855"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117109","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T12:56:56Z","timestamp":1721221016000},"page":"117109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Enhancing the efficacy of fluconazole against Leishmania major: Formulation and evaluation of FLZ-nanoemulsions for topical delivery"],"prefix":"10.1016","volume":"178","author":[{"given":"Manizheh Kashi","family":"Nahanji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Mahboobian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Larki","family":"Harchegani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mohebali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3567-8677","authenticated-orcid":false,"given":"Alireza","family":"Nourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedmousa","family":"Motavallihaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Maghsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2024.117109_bib1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/pathogens11080921","article-title":"Non-endemic leishmaniases reported globally in humans between 2000 and 2021\u2014a comprehensive review","volume":"11","author":"Rocha","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.biopha.2024.117109_bib2","unstructured":"WHO Global Health Observatory: Leishmaniasis. Available online:. \u3008https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/gho-ntd-leishmaniasis\u3009. (accessed on 2023)."},{"issue":"3","key":"10.1016\/j.biopha.2024.117109_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/scipharm87030017","article-title":"Nanoemulsion: a review on mechanisms for the transdermal delivery of hydrophobic and hydrophilic drugs","volume":"87","author":"Shaker","year":"2019","journal-title":"Sci. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2024.117109_bib4","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1039\/C5SM02958A","article-title":"Nanoemulsions: formation, properties and applications","volume":"12","author":"Gupta","year":"2016","journal-title":"Soft Matter"},{"key":"10.1016\/j.biopha.2024.117109_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12639-020-01318-1","article-title":"A nanoemulsion-based nanogel of Citrus limon essential oil with leishmanicidal activity against Leishmania tropica and Leishmania major","volume":"45","author":"Zarenezhad","year":"2021","journal-title":"J. Parasit. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.117109_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2173335","article-title":"Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis","volume":"30","author":"Anjum","year":"2023","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2024.117109_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-021-00902-z","article-title":"Besifloxacin-loaded ocular nanoemulsions: design, formulation and efficacy evaluation","volume":"11","author":"Kassaee","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.117109_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/1574885518666230804120659","article-title":"Preparation of ketoconazole-loaded nanoemulsions for ophthalmic delivery: characterization and in-vitro antifungal activity evaluation","volume":"19","author":"Mahboobian","year":"2024","journal-title":"Curr. Drug Ther."},{"issue":"4","key":"10.1016\/j.biopha.2024.117109_bib9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.sjbs.2020.02.014","article-title":"A comparative ex vivo permeation evaluation of a novel 5-Fluorocuracil nanoemulsion-gel by topically applied in the different excised rat, goat, and cow skin","volume":"27","author":"Ahmad","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.117109_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-5173(89)90306-2","article-title":"A simple equation for the description of solute release. III. Coupling of diffusion and relaxation","volume":"57","author":"Peppas","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117109_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.colsurfb.2015.03.062","article-title":"Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: In vitro, ex vivo and in vivo characterization","volume":"130","author":"Alvarado","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.biopha.2024.117109_bib12","article-title":"Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis","volume":"59","author":"Algahtani","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117109_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/08839115231167587","article-title":"Fabrication of poloxamer based besifloxacin thermosensitive in situ gelling nanoemulsions for ophthalmic delivery","volume":"38","author":"Kassaee","year":"2023","journal-title":"J. Bioact. Compat. Polym."},{"key":"10.1016\/j.biopha.2024.117109_bib14","first-page":"27","article-title":"Sterol profiling of Leishmania parasites using a new HPLC-tandem mass spectrometry-based method and antifungal azoles as chemical probes reveals a key intermediate sterol that supports a branched ergosterol biosynthetic pathway","volume":"20","author":"Feng","year":"2022","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"key":"10.1016\/j.biopha.2024.117109_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.937910","article-title":"Endogenous sterol synthesis is dispensable for Trypanosoma cruzi epimastigote growth but not stress tolerance","volume":"13","author":"Dumoulin","year":"2022","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117109_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003588","article-title":"Targeting ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14alpha-demethylase","volume":"9","author":"McCall","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2024.117109_bib17","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2024.117109_bib18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2010.04.014","article-title":"Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial","volume":"64","author":"Emad","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117109_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jsps.2017.12.016","article-title":"Role of chitosan on controlling the characteristics and antifungal activity of bioadhesive fluconazole vaginal tablets","volume":"26","author":"Fitaihi","year":"2018","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.biopha.2024.117109_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-020-00472-8","article-title":"Treatment strategies for asthma: reshaping the concept of asthma management","volume":"16","author":"Papi","year":"2020","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.biopha.2024.117109_bib21","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Roatt","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"12","key":"10.1016\/j.biopha.2024.117109_bib22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3390\/nano9121749","article-title":"Applications of nanomaterials in leishmaniasis: a focus on recent advances and challenges","volume":"9","author":"Saleem","year":"2019","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2024.117109_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/nnm-2022-0198","article-title":"Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer","volume":"18","author":"Shahidi","year":"2023","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2024.117109_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12645-023-00212-8","article-title":"HB5 aptamer-tagged graphene oxide for co-delivery of doxorubicin and silibinin, and highly effective combination therapy in breast cancer","volume":"14","author":"Shahidi","year":"2023","journal-title":"Cancer Nanotechnol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117109_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/bioengineering9040158","article-title":"Microemulsions and nanoemulsions in skin drug delivery","volume":"9","author":"Souto","year":"2022","journal-title":"Bioengineering"},{"key":"10.1016\/j.biopha.2024.117109_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.804415","article-title":"Transdermal delivery of therapeutic compounds with nanotechnological approaches in psoriasis","volume":"9","author":"Li","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117109_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1350-9462(01)00017-9","article-title":"Microemulsions as ocular drug delivery systems: recent developments and future challenges","volume":"21","author":"Vandamme","year":"2002","journal-title":"Prog. Retin. eye Res."},{"key":"10.1016\/j.biopha.2024.117109_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2012.09.032","article-title":"Penetration enhancers","volume":"64","author":"Williams","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.117109_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/pharmaceutics15010164","article-title":"Nanoemulgel: a novel nano carrier as a tool for topical drug delivery","volume":"15","author":"Donthi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.biopha.2024.117109_bib30","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3390\/pharmaceutics13071024","article-title":"Nanoemulsions: A review on the conceptualization of treatment for psoriasis using a \u2018green\u2019surfactant with low-energy emulsification method","volume":"13","author":"Dinshaw","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117109_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1208\/pt0804104","article-title":"Nanoemulsions as vehicles for transdermal delivery of aceclofenac","volume":"8","author":"Shakeel","year":"2007","journal-title":"Aaps Pharmscitech"},{"key":"10.1016\/j.biopha.2024.117109_bib32","unstructured":"Food, Administration D. DIFLUCAN\u00ae(Fluconazole Tablets)(Fluconazole for Oral Suspension)[displayed 2 March 2015]."},{"key":"10.1016\/j.biopha.2024.117109_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultsonch.2022.105926","article-title":"Continuous production of nanoemulsion for skincare product using a 3D-printed rotor-stator hydrodynamic cavitation reactor","volume":"83","author":"Matman","year":"2022","journal-title":"Ultrason. Sonochem."},{"issue":"3","key":"10.1016\/j.biopha.2024.117109_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1208\/s12249-020-1620-8","article-title":"Bromocriptine nanoemulsion-loaded transdermal gel: optimization using factorial design, in vitro and in vivo evaluation","volume":"21","author":"Sita","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.biopha.2024.117109_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/1381612826666191226100241","article-title":"Nanoemulgel: A promising phase in drug delivery","volume":"26","author":"Aithal","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.biopha.2024.117109_bib36","first-page":"33","article-title":"Skin surface pH in acne vulgaris: insights from an observational study and review of the literature","volume":"10","author":"Prakash","year":"2017","journal-title":"J. Clin. Aesthetic Dermatol."},{"issue":"9","key":"10.1016\/j.biopha.2024.117109_bib37","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/1346-8138.14489","article-title":"pH in nature, humans and skin","volume":"45","author":"Proksch","year":"2018","journal-title":"J. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117109_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/cosmetics8030069","article-title":"Towards optimal ph of the skin and topical formulations: From the current state of the art to tailored products","volume":"8","author":"Luki\u0107","year":"2021","journal-title":"Cosmetics"},{"issue":"4","key":"10.1016\/j.biopha.2024.117109_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5958\/2231-5713.2016.00033.7","article-title":"Calculation of predominant drug release mechanism using Peppas-Sahlin model, Part-I (substitution method): A linear regression approach","volume":"6","author":"Baggi","year":"2016","journal-title":"Asian J. Pharm. Technol."},{"key":"10.1016\/j.biopha.2024.117109_bib40","article-title":"Formulation and optimization of cationic nanoemulsions for enhanced ocular delivery of dorzolamide hydrochloride using Box-Behnken design: In vitro and in vivo assessments","volume":"68","author":"Kassem","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2024.117109_bib41","series-title":"The ADME Encyclopedia: A Comprehensive Guide on Biopharmacy and Pharmacokinetics","first-page":"613","article-title":"Korsmeyer-Peppas, Peppas-Sahlin, and Brazel-Peppas: Models of Drug Release","author":"Talevi","year":"2022"},{"issue":"4","key":"10.1016\/j.biopha.2024.117109_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1061186X.2017.1387787","article-title":". A new nanoemulsion formulation improves antileishmanial activity and reduces toxicity of amphotericin B","volume":"26","author":"Santos","year":"2018","journal-title":"J. Drug Target."},{"issue":"4","key":"10.1016\/j.biopha.2024.117109_bib43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/colloids6040064","article-title":"Stability Studies and the In Vitro Leishmanicidal Activity of Hyaluronic Acid-Based Nanoemulsion Containing Pterodon pubescens Benth.","volume":"6","author":"Kleinubing","year":"2022","journal-title":"Oil. Colloids Interfaces"},{"issue":"1","key":"10.1016\/j.biopha.2024.117109_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-022-02455-8","article-title":"Anti-leishmanial effects of resveratrol and resveratrol nanoemulsion on Leishmania major","volume":"22","author":"Mousavi","year":"2022","journal-title":"BMC Microbiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117109_bib45","first-page":"622","article-title":"Antileishmanial activity of Lavandula angustifolia and Rosmarinus officinalis essential oils and nano-emulsions on Leishmania major (MRHO\/IR\/75\/ER)","volume":"12","author":"Shokri","year":"2017","journal-title":"Iran. J. Parasitol."},{"issue":"14","key":"10.1016\/j.biopha.2024.117109_bib46","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1111\/bph.13149","article-title":"Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy","volume":"172","author":"Gupta","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117109_bib47","article-title":"Polyene macrolide antibiotic nanoemulsion: a proposal for the treatment of cutaneous leishmaniasis","volume":"7","author":"Sosa","year":"2022","journal-title":"Revis Bionat."},{"issue":"5","key":"10.1016\/j.biopha.2024.117109_bib48","doi-asserted-by":"crossref","first-page":"414","DOI":"10.32598\/qums.16.5.377.1","article-title":"In-vitro study on the anti-leishmania effects of silver nanoparticles on leishmanaia major promastigotes","volume":"16","author":"Norouzi","year":"2022","journal-title":"Qom Univ. Med. Sci. J."},{"issue":"5)","key":"10.1016\/j.biopha.2024.117109_bib49","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.chom.2020.03.011","article-title":"Th1-Th2 cross-regulation controls early Leishmania infection in the skin by modulating the size of the permissive monocytic host cell reservoir","volume":"27","author":"Carneiro","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.biopha.2024.117109_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2567.2009.03223.x","article-title":"Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors","volume":"130","author":"Kumar","year":"2010","journal-title":"Immunology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224009934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224009934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:27:44Z","timestamp":1777861664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224009934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":50,"alternative-id":["S0753332224009934"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117109","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the efficacy of fluconazole against Leishmania major: Formulation and evaluation of FLZ-nanoemulsions for topical delivery","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117109"}}